3 results
Approved WMOCompleted
This study will evaluate 2 different treatment strategies : a combination of S 95005 and bevacizumab (experimental combination) and a combination of capecitabine and bevacizumab (control arm) as first-line treatment for metastatic colorectal cancer…
Approved WMORecruiting
To compare two (standard) treatment regimens in patients with KRAS mutated advanced stage NSCLC as first line treatment.
Approved WMORecruiting
Objectives of the phase II study (80 patients) are to explore the feasibility of accrual, the feasibility, safety, and tolerance of perioperative systemic therapy, and the radiological and histological response of colorectal PM to neoadjuvant…